World's Best Scientists 2026 revealed!
D. Lorne Tyrrell

D. Lorne Tyrrell

D-Index & Metrics

Immunology

D-Index
56
Citations
10443
World Ranking
3736
National Ranking
97

D. Lorne Tyrrell publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where D. Lorne Tyrrell sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 217 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

D. Lorne Tyrrell D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where D. Lorne Tyrrell sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2015 - Izaak Walton Killam Memorial Prize, Canada Council
  • 2004 - Fellow of the Royal Society of Canada Academy of Science

Overview

D. Lorne Tyrrell is affiliated with the University of Alberta in Canada and specializes in the field of Medicine with a primary focus on Infectious Diseases, Molecular Biology, Epidemiology, Immunology, and Computational Theory and Mathematics.

Their research encompasses several critical topics including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Computational Drug Discovery Methods
  • Viral Gastroenteritis Research and Epidemiology
  • Hepatitis C Virus Research
  • SARS-CoV-2 Detection and Testing
  • Animal Virus Infections Studies

Recent significant publications by D. Lorne Tyrrell include:

  • "Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication," 2020, Nature Communications
  • "Molecular Diagnosis of COVID-19: Challenges and Research Needs," 2020, Analytical Chemistry
  • "CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules," 2021, Chemical Science
  • "Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor," 2020, Nature Genetics
  • "Isothermal Amplification and Ambient Visualization in a Single Tube for the Detection of SARS-CoV-2 Using Loop-Mediated Amplification and CRISPR Technology," 2020, Analytical Chemistry

Their work has appeared most frequently in the following publication venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Analytical Chemistry
  • Nature Communications
  • Microbiology Spectrum
  • ACS Measurement Science Au

Frequent co-authors collaborating with D. Lorne Tyrrell are:

  • Michael Joyce
  • Holly A. Saffran
  • Michael Houghton
  • Elena Arutyunova
  • M. Joanne Lemieux

D. Lorne Tyrrell has been recognized with the following awards:

  • Izaak Walton Killam Memorial Prize, Canada Council, 2015
  • Fellow of the Royal Society of Canada (Academy of Science), 2004

Best Publications

  • Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.

    Wayne Vuong;Muhammad Bashir Khan;Conrad Fischer;Elena Arutyunova

  • Treatment of Recurrent Genital Herpes Simplex Infections With Oral Acyclovir: A Controlled Trial

    R C Reichman;G J Badger;G J Mertz;L Corey

  • Molecular Diagnosis of COVID-19: Challenges and Research Needs.

    Wei Feng;Ashley M. Newbigging;Connie Le;Bo Pang

  • Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery

    Carrie S.W. Chong;Min Cao;Winnie W. Wong;Karl P. Fischer

  • Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor.

    Olusegun O. Onabajo;A. Rouf Banday;Megan L. Stanifer;Wusheng Yan

  • Isothermal Amplification and Ambient Visualization in a Single Tube for the Detection of SARS-CoV-2 Using Loop-Mediated Amplification and CRISPR Technology.

    Bo Pang;Jingyang Xu;Yanming Liu;Hanyong Peng

  • Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial.

    Jordan J Feld;Jordan J Feld;Christopher Kandel;Mia J Biondi;Mia J Biondi;Robert A Kozak

  • Structural Polypeptides of Measles Virus

    David L. J. Tyrrell;Erling Norrby

  • HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus.

    Norman M. Kneteman;Anita Y. M. Howe;Tiejun Gao;Jamie Lewis

  • A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans.

    John Lok Man Law;Chao Chen;Jason Wong;Darren Hockman

  • IFITM1 is a tight junction protein that inhibits hepatitis C virus entry

    Courtney Wilkins;Jessica Woodward;Daryl T.-Y. Lau;Amy Barnes

  • The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections.

    Adrian Egli;Deanna M Santer;Daire O’Shea;D Lorne Tyrrell

  • Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses

    Mireille R. St.Vincent;Che C. Colpitts;Alexey V. Ustinov;Muhammad Muqadas

  • HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice

    Michael A. Joyce;Kathie Anne Walters;Sue Ellen Lamb;Mathew M. Yeh

  • Half-Life of the Duck Hepatitis B Virus Covalently Closed Circular DNA Pool In Vivo following Inhibition of Viral Replication

    William R. Addison;Kathie-Anne Walters;Winnie W. S. Wong;John S. Wilson

  • Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virus.

    Yutaka Takebe;Carrie J. Saucedo;Garry Lund;Rie Uenishi

  • Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine

    Unknown

  • Comprehensive in vitro characterization of PD-L1 small molecule inhibitors

    Aravindhan Ganesan;Marawan Ahmed;Isobel Okoye;Elena Arutyunova

  • Anti‐HCV therapies in chimeric scid‐Alb/uPA mice parallel outcomes in human clinical application

    Norman M. Kneteman;Amy J. Weiner;John O'Connell;Marc Collett

  • The Hepatitis C Virus-Induced Membranous Web and Associated Nuclear Transport Machinery Limit Access of Pattern Recognition Receptors to Viral Replication Sites

    Christopher J. Neufeldt;Michael A. Joyce;Nicholas Van Buuren;Aviad Levin

  • Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry

    Liang Tzung Lin;Chueh Yao Chung;Wen Chan Hsu;Shun Pang Chang

  • Hepatitis C virus induced up‐regulation of microRNA‐27: A novel mechanism for hepatic steatosis

    Ragunath Singaravelu;Ran Chen;Rodney K. Lyn;Daniel M. Jones

  • IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza

    Adrian Egli;Deanna M. Santer;Daire O'Shea;Khaled Barakat

Frequent Co-Authors

Michael Houghton
Michael Houghton University of Alberta
Rakesh K. Kumar
Rakesh K. Kumar University of New South Wales
John C. Vederas
John C. Vederas University of Alberta
John Paul Pezacki
John Paul Pezacki University of Ottawa
Christopher D. Richardson
Christopher D. Richardson Dalhousie University
X. Chris Le
X. Chris Le University of Alberta
Steeve Boulant
Steeve Boulant University of Florida
Marc S. Collett
Marc S. Collett Takeda (United States)
Jason Grebely
Jason Grebely University of New South Wales
Mel Krajden
Mel Krajden University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to various healthcare roles, many of which can be complemented by online programs. For those looking to transition into nursing without prior experience, online accelerated nursing programs for non nurses offer an efficient pathway.

If entry competition is a concern, prospective students might explore absn programs with high acceptance rates. These programs provide flexibility and accessibility, helping learners advance quickly.

For those interested in practical nursing roles, investigating easy admission lpn programs can be beneficial. LPN training serves as a strong foundation for patient care within immunology-related settings.

Advanced practice nurses focusing on immunology may find easiest online nurse practitioner programs valuable. These programs provide specialized knowledge and credentials to lead immunology patient management and research.

Best Scientists Citing D. Lorne Tyrrell

Trending Scientists

Recently Published Articles